William Blair & Company
HGEN

William Blair & Company’s HUMANIGEN, INC. HGEN Stock Holding History

William Blair & Company’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-20,000
Closed -$348K – 1967
2021
Q2 		$348K Buy
+20,000
New +$365K ﹤0.01% 1292

Other funds holding HGEN

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

William Blair & Company's HGEN Position: Q3 2021 in Review

William Blair & Company sold out of HUMANIGEN, INC. (HGEN) in Q3 2021, closing a stake of 20,000 shares — an estimated $348K sold.

William Blair & Company first reported a position in HGEN in Q2 2021 and held it in 1 quarter. The position peaked at $348K in Q2 2021. 85 funds tracked by Wall St. Rank hold HGEN as of Q3 2021.

  • William Blair & Company reported no remaining HUMANIGEN, INC. position as of Q3 2021 after selling out during the quarter.
  • William Blair & Company sold 20,000 HUMANIGEN, INC. shares in Q3 2021, an estimated $348K.
  • William Blair & Company first reported a position in HUMANIGEN, INC. in Q2 2021 and held it in 1 quarter.
  • William Blair & Company's HUMANIGEN, INC. position peaked at $348K in Q2 2021.
  • 85 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2021.

Based on William Blair & Company's 13F filing for Q3 2021, filed 12 Nov 2021.